A panel of murine monoclonal antibodies (MAbs) against the two major glycoproteins of bovine viral diarrhoea virus (BDV) was produced and assayed by serum neutralization, radioimmunoprecipitation (RIP) and immunoblotting. Based on their viral polypeptide specificity and on their ability to neutralize viral infectivity, the MAbs in the panel were divided into three classes : Class 1 MAbs reacted with the 56K to 58K glycoprotein and neutralized the virus, class 2 MAbs recognized the 56K to 58K glycoprotein but were not neutralizing, and class 3 MAbs reacted with the 48K glycoprotein and did not neutralize the virus. These results identify the 56K to 58K protein as one of the envelope glycoproteins of BDV. Evidence was obtained indicating that it is responsible for the induction of neutralizing antibodies. No large uncleared precursors of the 56K to 58K protein could be identified unequivocally by RIP of infected cell extracts, suggesting that this polypeptide is proteolytically processed cotranslationally. A subset of MAbs that reacted with BDV isolates of the noncytopathic biotypes yielded similar results, indicating that these findings are applicable to both biotypes of BDV.
INTRODUCTION
Bovine viral diarrhoea virus (BDV) is a member of the genus Pestivirus in the family Togaviridae. It is currently considered to be among the most important viral pathogens of cattle world-wide. Since the description of the disease syndromes caused by the virus by Olaf son et al. in 1946 (Olafson et al., 1946 Olafson & Rickard, 1947) and the isolation of the virus in tissue cultures by Lee & Gillespie (1957) it has been one of the most elusive agents for both virologists and clinicians. Recent work, however, has significantly contributed to our understanding of the pathobiology of BDV infections. The pathogenetic mechanisms leading to disease in cattle are unique among animal viruses. A transplacental infection of the foetus with a non-cytopathic biotype of BDV (NCB-BDV) may under certain conditions lead to a persistent infection of the newborn (McClurkin et al., 1984) . If superinfected with certain cytopathic biotypes of BDV (CB-BDV), these persistently infected animals often die with the classic lesions described for bovine virus diarrhoea (Brownlie et al., 1984; Bolin et al., 1985) . The molecular determinants of the pathogenetic mechanisms remain largely unknown.
We have recently reported on the identification of BDV proteins induced in infected cells and on the differences in the proteins between CB-BDV and NCB-BDV (Donis & Dubovi, 1987a, b, c) . A total of 12 polypeptides were identified in BDV-infected cell extracts (Mr 165, 135, 118, 80, 75, 62, 56 to 58, 48, 37, 32, 25 and 19, all x 103) . Of the major polypeptides (Mr 118, 80, 56 to 58, 48, 37 and 19, all × 103) , only the 56K to 58K and 48K species contained a significant amount of carbohydrate. The polypeptides induced by a NCB-BDV infection were similar to those induced by CB-BDV with the major exception that the 80K protein was "j" Present address: Department of Virology, St Jude Children's Hospital, Memphis, Tennessee 38101, U.S.A. 0000-7823 © 1988 SGM consistently absent from NCB-BDV-infected cell extracts (Donis & Dubovi, 1987c) . The function of the various viral polypeptides has not been determined. Here we report on the preparation of a panel of monoclonal antibodies (MAbs) to the two major viral glycoproteins and on some of their biological activities including their ability to neutralize viral infectivity and their binding specificity. These results have identified the viral glycoprotein responsible for the induction of neutralizing antibodies in cattle infected with BDV.
METHODS

Cell cultures and virus.
Murine myeloma P3-X63-Ag8.653 cells (Repository GM35070B, Institute for Medical Research, Camden, N.J., U.S.A.) were cultured in RPMI 1640 medium (Gibco) supplemented with 20 mM-HEPES, 4 mM-L-glutamine, 50 llM-2-mercaptoethanol, 100 IU/ml penicillin, 100 l.tg/ml streptomycin (Sigma) and 15 % donor horse serum (MA Bioproducts, Walkersville, Md., U.S.A.). Foetal bovine testicle (FBT) cells prepared by standard trypsin dispersion methods were cultured in minimum essential medium with Earle's salts (MEME) supplemented with 10% lamb serum (Gibco) and antibiotics. Cell cultures used in these experiments were determined to be free of NCB-BDV and mycoplasma. BDV (NY-I, a non-cytopathic biotype isolate) was obtained from the American Type Culture Collection (Baker et al., 1954) . The Singer cytopathic isolate of BDV was obtained from National Veterinary Service Laboratories, Ames, Iowa, U.S.A. (McClurkin et al., 1974) . The CB-BDV was plaque-purified twice while the NCB-BDV was cloned by limiting dilution. Stocks were prepared in FBT cells and stored frozen at -70 °C.
Production of monoclonal antibodies. The Singer isolate of BDV was used to immunize mice as a source of lymphocytes to fuse to myeloma cells for hybridoma production (Fazekas de St. Groth & Scheidegger, 1980) . FBT cells were grown in roller bottles (Coming) until confluent in MEME with 5% lamb serum. The cells were infected at an input multiplicity of 0.1 TCIDso/cell and overlaid with MEME with 2% lamb serum. The culture fluid was harvested at 36 h post-infection, before any evidence of extensive cytopathology. The virus was concentrated 10fold in a tangential flow ultrafdtration device (Millipore) fitted with a 100 000 Mr cutoff membrane (Mathes et al., 1977) and then applied to a step gradient of 15% to 35% (w/v) sucrose. The gradient was centrifuged at 27000 r.p.m, in a SW28 rotor for 3 h at 4°C.
The material collected at the 15 % to 35 % sucrose interphase was harvested and used to immunize mice without further purification. Female 6 to 8 week old BALB/c mice (Jackson Laboratories, Bar Harbor, Me., U.S.A.) were inoculated intraperitoneally with 200 ~tl (100 ~tg protein, approximate infectivity of 109 TCID50) of gradientconcentrated virus mixed with 200 ~tl of complete Freund's adjuvant (Difco). Mice were boosted twice with the same preparation in incomplete Freund's adjuvant intraperitoneally 4 weeks apart and again 3 days before the fusion by intrasplenic injection of antigen (50 ~tg protein) without adjuvant Thorpe et al., 1984; Witte & Ber, 1983) . Fusion was carried out as described (Hancock & Tsang, 1983 ) using P3-X63-Ag8.653 myeloma cells at the fusion partner (Keamey et al., 1979) .
Screening of hybrids was carried out by testing the supernatant from individual wells in an indirect immunofluorescence assay (IFA) carried out on multispot Teflon-coated (HTC) microscope slides (Cell-Line Associates, Newfield, N.J., U.S.A.). A subset of the original hybrids in the first fusion was also screened by serum neutralization (SN) assay at a single 1/10 dilution against 100 TCIDso of BDV in a standard test, using FBT cells as indicators (see below). Hybrids secreting immunoglobulin reactive with infected cells exclusively or capable of neutralizing infectivity were cloned twice by limiting dilution in 96-well plates containing a feeder layer of 2 x 104 to 4 x 104 routine peritoneal lavage cells.
For MAb production as ascites tumours, approximately 107 cells from each hybridoma were injected intraperitoneally into 6 to 8 week old female BALB/c mice which had received a previous injection of pristane or incomplete Freund's adjuvant to facilitate the growth of the hybridoma cells in the peritoneal cavity (Brodeur et al., 1984) .
Isotopic labelling and preparation of cell extracts. The procedure used in radiolabelling infected cells and the preparation of cell extracts for radioimmunoprecipitation (RIP) have been described (Donis & Dubovi, 1987a) .
Reduction and alkylation of cell extracts prior to RIP. Cell extracts were diluted in a buffer containing 50 mM-Tris-HCI, 150 mM-NaCI, 5 m~-EDTA, pH 7.4 (TNE buffer) supplemented with 0.5% Triton X-100, 0.1% SDS, 0.5~ sodium deoxycholate and 100 ItM-PMSF (TNE/RIP buffer). Reduction and alkylation prior to RIP were as follows. Cell extracts (28 ~tg protein) were made 10 rnM in dithiothreitol (DTT) and incubated at 37 °C for 2 h. Reduced cysteine residues were then carboxymetbylated by adding iodoacetamide to a final concentration of 100 mM and incubating at 22 °C for 30 min. The extracts were diluted 1 : 30 in TNE/RIP buffer and used for RIP.
Radioimmunoprecipitation. Cell extracts centrifuged at 10000 g for 5 rain to eliminate insoluble matter were adjusted to give final concentrations of 1% Triton X-100, 0.5 % sodium deoxycholate and 0-1% SDS in TNE buffer containing 100 ~tM-PMSF. To aliquots of a cell extract containing approximately 2 × 106 d.p.m., 10 ~tl of ascitic fluid or anti-BDV hyperimmune serum was added followed by mixing and overnight incubation at 4 °C. The IP: 54.70.40.11
On: Wed, 31 Jul 2019 21:07:45 BDV neutralization epitope 79 immune complexes were isolated by adding 100 ~tl per reaction mixture of a 10% suspension of Protein Acontaining fixed Staphylococcus aureus, strain Cowan I (Pansorbin, Calbiochem-Behring) which had been washed three times with TNE/RIP, and then incubated for 1 h at 37 °C with a solution of 1 ~o dehydrated skim milk in TNE/RIP and washed once again before use as indicated above. Following incubation at room temperature for 1 h on a rocking platform, the immune complexes bound to the immunosorbent were collected by centrifugation at 2000 g for 3 min. The immunosorbent pellets were rinsed four times with TNE/RIP. The immune complexes were eluted from the immunosorbent by boiling in electrophoresis sample buffer (65 mM-Tris-HC1, 2~ SDS, 10 mM-DTT, 0.001 ~o bromophenol blue, pH 8.0) for 4 min. The immunosorbent was removed by centrifugation at 10000 g for 5 min. The isolated immune complexes were made 100 mM in iodoacetamide, incubated for 30 min at 25 °C and stored frozen at -20 °C until needed.
Polyacrylamide gelelectrophoresis. SDS-PAGE was performed in a discontinuous buffer system as described by Laemmli (1970) . The acrylamide concentration was 3~ in the stacking gel and 10% in the resolving gel. After electrophoresis, gels were treated for fluorography and autoradiography as described (Donis & Dubovi, 1987a). 1mmunoblotting. Approximately 5 x 106 FBT cells were infected or mock-infected with CB-BDV. At 18 h postinfection the cells were lysed in 1 ml of electrophoresis sample buffer (65 mM-Tris-HC1 pH 6.8, 2~ SDS, 25 mM-DTT), the DNA was sheared by passage through a narrow gauge needle and the resulting lysate was boiled for 4 min. Insoluble material was pelleted by centrifugation at 10000 g for 10 min at 4 °C and the supernatant fluid was stored at -70 °C until used. Aliquots of infected and mock-infected cell lysate were separated by SDS-PAGE as described above. After electrophoresis, the gels were rinsed in three changes of 20 raM-sodium phosphate buffer pH 6.5 (20 min each rinse) to eliminate SDS. The proteins were electroblotted at 0.9 A for 2 h in sodium phosphate buffer pH 6-5. After transfer, the nitrocellulose membrane was blocked overnight with 1 ~ skim milk in TNE/W (TNE containing 0.05~ Tween 20). An unblocked control strip was stained with Indian ink to monitor the efficiency of transfer (Hancock & Tsang, 1983) . Blocked nitrocellulose sheets were then incubated for 2 h at 25 °C with either hyperimmune bovine anti-BDV polyclonal serum (diluted 1:500 in TNE/W), MAb ascites fluids (diluted 1 : 500 in TNE/W) or hybridoma cell culture supernatants (diluted 1 : 10). After washing three times with TNE/W, the membranes were incubated with the appropriate dilution of affinity-purified rabbit anti-bovine IgG or anti-mouse IgG (BMB, Indianapolis, Ind., U.S.A.) and washed again as described above. Bound IgGs were detected with 12SI-labelled Protein A (sp. act. 34 ~tCi/~tg) (ICN) by incubating the membranes with 400000 d.p.m./ml of 125I-labelled Protein A in TNE/W for 1 h at 37°C, followed by four washes in TNE/W. Autoradiography was performed using an enhancing screen (Eastman Kodak).
RESULTS
Hybridoma production
Approximately 200 different cultures containing hybrids secreting antibodies to BDVencoded polypeptides in infected cells were identified by IFA and SN assays from two fusion experiments. Thirty of these were selected for recloning and ascitic fluid production. A large proportion (75~) of the hybrids that were positive by IFA in the first fusion experiment were found to neutralize viral infectivity in the SN assay. In addition, no hybrids were detected that secreted neutralizing antibodies but were non-reactive in the IFA assay.
SN and RIP assays
When the MAbs were used in SN tests and RIP assays of BDV-infected cell extracts, we detected the presence of three classes of reactivity in these antibodies (Table 1) . Class 1 MAbs reacted with the 56K to 58K glycoprotein of BDV and neutralized viral infectivity (Fig. 1, lane  8; Fig. 2, lane 8) . Class 2 MAbs reacted with the 56K to 58K glycoprotein in RIP assays but did not neutralize the virus (Fig. 1, lanes 10, 12 and 14) . The single class 3 MAb reacted in RIP with the 48K glycoprotein and was not neutralizing (Fig. 2, lane 6; Fig. 5, lane 4) .
These patterns should not be interpreted to mean that all antibodies within a given class recognize the same epitope in the viral glycoproteins. Although we have not yet performed competition analyses to map the epitopes recognized by each MAb, we have derived similar information through testing each MAb against a limited panel of different viral isolates. MAbs that belong to a given class react with different sets of viral isolates, indicating that different epitopes are being recognized (Table 1, class 2). If this were not the case, all MAbs in a given class would react with exactly the same set of isolates. 3 and 4) , class 3 MAb 15C5 (lanes 5 and 6), class 1 MAb 17x4.9 (lanes 7 and 8) and polyclonal mouse antisera to the molecularly cloned 56K to 58K glycoprotein of BDV (lanes 9 to 12). Cells were infected with NCB-BDV as described in Fig. 1 (lanes 2, 4, 6 , 8, 10 and 12) or mock-infected with medium only (lanes 1, 3, 5, 7, 9 and 11).
RIP assays of reduced and alkylated extracts
In some of the R I P assays carried out with M A b s of classes 1, 2 and 3 using the standard protocols, we detected small amounts of the 118K and 75K viral polypeptides (Fig. 1, 2 and 5 ). In addition, R I P assays with the class 3 M A b resulted in a trace of 56K to 58K protein being precipitated (Fig. 5, lane 4) whereas in assays with class 1 and 2 M A b s some 48K was 
*+, Positive reaction on IFA; -, negative reaction on IFA. 81 precipitated (Fig. 1) . The relatively small amounts of these proteins in the immunoprecipitates suggested that they were co-precipitated after their interaction with the polypeptides recognized specifically by the MAbs. To clarify this problem of potential co-precipitation, we studied the effects of reducing and alkylating the polypeptides before the RIP assays. The reduction and alkylation (carboxymethylation) of the extracts prior to the RIP resulted in the immunoprecipitation of the 56K to 58K glycoprotein exclusively by some of the MAbs (Fig. 3, lanes 3 and 4) . Most of the MAbs reacted with these reduced polypeptides, suggesting that the immunoreactivity of the epitopes did not depend on disulphide bonds that were eliminated as a result of the treatment with reducing agent and iodoacetamide. However, MAb 15C5 was found to lose its reactivity when disulphide bonding was disrupted (Fig. 3, lane 1) .
Immunoblotting
The reactivity of polyclonal anti-BDV bovine serum indicated that the 118K, 80K and 56K to 58K polypeptides could be detected on nitrocellulose sheets after transfer (Fig. 4, lane 2) . The reactivity of the 56K to 58K polypeptide was, however, weaker than that of the 118K and 80K proteins. Several reasons could account for the lack of reactivity of other polypeptides such as those of Mr 75K, 48K and 37K. Poor transfer to the nitrocellulose membrane and/or impaired reactivity of the denatured polypeptide with the antibodies are worth considering. Our previous experience with proteins boiled in 2 ~ SDS and reducing agents prior to RIP assays supports the concept that denaturation is a major factor in the lack of reactivity of certain antigens in immunoblots (R. O. Donis & E. J. Dubovi, unpublished observations). Immunoblots with MAbs such as 15C5 indicated that some MAbs did not react at all under these conditions. Other MAbs such as most of the members of class 1 gave weak reactions on immunoblots. Members of class 2 gave the best reactivity, recognizing only the 56K to 58K glycoprotein (Fig. 4, lane 4) . The intensity of the signal obtained with some of the MAbs reactive with the 56K to 58K polypeptide was greater than that obtained with the polyclonal antiserum. No reactivity was detected with the 80K and l18K polypeptides in spite of their strong reactivity with the polyclonal antibodies (compare lanes 2 and 4 in Fig. 4) . These results suggest that the epitopes present in the 56K to 58K polypeptide recognized by the MAbs are not present in the 80K or 118K polypeptides.
Glycosylation of 56K to 58K and 48K polypeptides recognized by MAbs
The presence of oligosaccharides in the polypeptides recognized by these MAbs was confirmed by RIP of mannose-labelled infected cell extracts (Fig. 5 ). MAbs of class 1 reactivity immunoprecipitated a glycosylated 56K to 58K polypeptide (Fig. 5, lane 3) and the MAb of class 3 immunoprecipitated a glycosylated 48K polypeptide with a trace of 56K to 58K (Fig. 5, lane  4) . The presence of 75K was also noticeable in RIP assays with MAbs of these two different 1 and 3) FBT cell extracts were separated after reduction by SDS-PAGE and electroblotted onto nitrocellulose. Lanes 1 and 2 were probed with polyclonal antiserum to BDV; lanes 3 and 4 were probed with class 2 MAb 38C14. Binding was detected with ~2SI-labelled Protein A followed by autoradiography.
classes as noted previously. The presence of carbohydrate in the 48K protein further confirms that this polypeptide is not actin, a protein of similar Mr which is abundant in cell extracts and has a strong tendency to bind to Protein A-containing immunosorbents (Hayes et al., 1978) (Fig.   1, lanes 1, 7, 11 and 13 ).
lmmunofluorescence of B D V-infected cells
The patterns of fluorescence in BDV-infected FBT cells were similar for all the hybridomas tested. They consisted of a fine granular fluorescence surrounding the nucleus extending to and occupying most of the cytoplasm (Fig. 6a) . CB-BDV-and NCB-BDV-infected cells had essentially identical patterns of staining by IFA, but the intensity of fluorescence ~vas greater in cells infected with CB-BDV (Fig. 6a, b ). This distribution of viral antigen is most consistent with its localization in the rough endoplasmic reticulum (Ng et al., 1983) . When cells were stained with an antibody to the mannose-6-phosphate receptor protein which is present in high concentration in the cis-Golgi apparatus cisternae, the pattern observed was restricted to a capshaped area in the cytoplasm on one side of the nucleus (Fig. 6 c) (Brown & Farquar, 1984) . This is in agreement with previously reported patterns of staining of the Golgi apparatus with fluorescent antibody or lectin probes (Louvard et al., 1982) . Clearly, there is no selective accumulation of BDV glycoprotein in the Golgi apparatus of the infected cell. 3) and MAb 15C5 (lanes 2 and 4) .
DISCUSSION
The binding of class 1 MAbs to certain epitopes of the 56K to 58K glycoprotein resulted in virus neutralization. The mechanism of neutralization remains to be elucidated, but it is possible that this binding interferes with attachment of the virus to host cell receptors and/or fusion with the endosomal membrane, thereby preventing the release of the nucleocapsid into the cytosol. If this is the case, the 56K to 58K glycoprotein must contain epitopes present in a virion structural protein. The most likely candidate is the 56K glycosylated polypeptide found in purified viral preparations (A. Luukkonen-Soliman & E. J. Dubovi, unpublished results) . The 56K to 58K glycoprotein is either very abundant or very immunogenic in semi-purified virus preparations since the majority of the MAbs which we examined recognize this glycoprotein. It is reasonable to speculate that the same protein is also responsible for the induction of neutralizing antibodies in infected cattle. Serum from animals immunized with BDV compete with the binding of neutralizing MAbs in ELISA and IFA indicating that these epitopes are also recognized by the bovine immune system (data not shown).
The binding of class 2 and 3 MAbs to certain epitopes in the 56K to 58K and 48K glycoproteins did not neutralize viral infectivity, suggesting that they do not react with intact virions or that they react with an epitope that is not necessary for virus attachment or penetration. The addition of anti-mouse IgG + M + A to virus treated with class 2 or 3 MAbs did not affect the lack of virus neutralization, indicating that these MAbs do not bind to virions (data not shown).
The epitopes located in the 56K to 58K polypeptide that are recognized by the set of class 1 and 2 MAbs are absent from the 165K, l18K, 80K, 75K and 37K polypeptides present in infected cell extracts. However, small amounts of 118K and 75K were sometimes detected by RIP using MAbs of classes 1 and 2. Cells infected with NCB-BDV isolates contain a larger proportion of l18K polypeptide, making it the most abundant of the viral polypeptides. However, when extracts from cells infected with NCB-BDV were immunoprecipitated, the amounts of 118K were still minor. This suggests a lack of epitopes shared by this polypeptide and the 56K to 58K polypeptide. Alternatively, there may be a small proportion of the 118K polypeptide that is not bona fide 118K but actually a dimer of 56K which comigrates in the gel with 118K. The results of RIP assays with MAbs 6D11 and 27B3 using reduced and alkylated extracts ( Fig. 3 ) and the immunoblots (Fig. 4 ) support the contention that a small proportion of I18K is in fact co-precipitated with the 56K to 58K polypeptide. The presence of the 75K protein found in RIP assays using both class 1 and 2 MAbs is also considered to result from a non-antigenic co-precipitation for the following reasons. The polyclonal mouse serum produced against a molecularly cloned portion of the 56K to 58K glycoprotein does not react with the 75K glycoprotein (Fig. 2, lanes 10 and 12) . This indicates that the 56K to 58K protein does not contain antigenic sites in common with 75K, which argues against 75K being a precursor to this glycoprotein. Additionally, the absence of 75K in the RIP assays using reduced and alkylated extracts supports the idea of co-precipitation. The data are less clear with the MAb specific for the 48K glycoprotein, but the lack of consistency in precipitating 75K with the class 3 MAb suggests a lack of antigenic identity between these two proteins as well.
Since the coding capacity of the genomic RNA which acts as a message for the translation of the structural and non-structural polypeptides is significantly smaller than the sum of the molecular weights of all the polypeptides detected in infected cells, we have postulated that some of the proteins detected in infected cells are unprocessed precursors (Donis & Dubovi, 1987a) . The results presented here suggest that the 165K, l18K and 80K polypeptides are not the precursors of the 56K to 58K and 48K glycoproteins. Assuming that viral polypeptides are translated from a polycistronic message and subsequently proteolytically processed, the inability to identify an uncleaved large polypeptide that could be the precursor of 56K to 58K suggests that this polypeptide is proteolytically cleaved cotranslationally.
Of the 24 MAbs examined so far, approximately half of them react with a set of NCB-BDV isolates. These MAbs from all three reactivity classes give RIP and SN results essentially identical to those obtained with the cytopathic BDV Singer isolate (data not shown) (see Fig. 2 , lanes 6 and 8 for the RIP reactivity with a prototype isolate of NCB-BDV). These results suggest that the major difference between the polypeptides synthesized in infected cells by the two biotypes of BDV (the presence of 80K for CB-BDV isolates and its absence for NCB-BDV isolates) is independent from the epitope diversity detected by our MAbs. This supports our belief that for BDV biotypic and antigenic variation are two independent variables (W. Corapi, R. O. Donis & E. J. Dubovi, unpublished results).
The strong bias towards MAbs directed against the 56K to 58K polypeptides is remarkable. The mouse IgG response included specificities against all the major polypeptides present in BDV-infected cells (Fig. 1, lane 2) , and this response was very similar to the response of the natural host, cattle (Fig. 1, lane 6 ; Donis & Dubovi, 1987 d) . No MAbs have been detected which react specifically with the 118K and 80K polypeptides even though these two putative nonstructural proteins are consisiently found in gradient-purified virus preparations (Purchio et al., 1984 ) (A. Luukkonen & E. J. Dubovi, unpublished observations). Of 24 MAbs so far characterized only one is not directed against the 56K to 58K protein. The absence of MAbs to the 80K and 118K polypeptides is intriguing and cannot be explained at the present time. We have no evidence suggesting that the bias in the kind of MAbs obtained is the result of the screening methodology although our interest in neutralizing MAbs may have produced a bias in the selection of the initial cultures for subcloning.
The reactivity of polyclonal mouse antiserum raised against a cloned 56K to 58K glycoprotein inserted in a vaccinia virus expression vector paralleled and confirmed the results obtained with the MAbs (Fig. 2, lanes 10 and 12) (Dubovi et al., 1987) . These monospecific polyclonal antibodies have the same polypeptide specificity as the class 1 and 2 MAbs and also neutralize viral infectivity as do class 1 MAbs. These results confirm our finding that the 56K to 58K glycoprotein contains neutralization epitopes.
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